Can antipsychotic medications cause increased urine output (polyuria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Antipsychotics Cause Increased Urine Output?

Yes, antipsychotics can cause increased urine output (polyuria), though the mechanism and prevalence varies by agent, with clozapine being particularly associated with nocturnal enuresis and urinary incontinence affecting up to 40% of patients. 1

Understanding the Urinary Effects

Antipsychotics cause a spectrum of urinary disturbances, not simply increased output. The effects include:

  • Polyuria (increased urine volume): 24-hour urinary volumes were 75% larger in schizophrenic patients on antipsychotics compared to controls, independent of increased water intake 2
  • Nocturnal enuresis and urinary incontinence: Affects up to 40% of clozapine-treated patients 1
  • Urge incontinence: 24% prevalence in antipsychotic-treated women versus 6% in controls 3
  • Nocturia: 15% in treated patients versus 3% in controls 3

Agent-Specific Considerations

Clozapine carries the highest risk. Among women with nocturnal enuresis on antipsychotics, 5 out of 12 were specifically on clozapine 3. The 2026 consensus guidelines explicitly list "nocturnal enuresis and urinary incontinence" as a monitored adverse drug reaction for clozapine 1.

Other atypical antipsychotics show variable effects. Quetiapine demonstrated higher odds of voiding dysfunction compared to other atypical antipsychotics (OR: 2.14; CI: 1.41-3.26) 4. Overall, antipsychotics in dementia patients showed increased incontinence risk (OR: 4.09; CI: 1.71-9.79) 4.

Clinical Approach to Monitoring

The 2026 clozapine guidelines mandate screening for "nocturnal enuresis and urinary incontinence" at every adverse drug reaction monitoring visit 1. This should occur:

  • With ANC testing appointments for the first 2 years
  • Every 3 months after 2 years of treatment

Approach these discussions with normalizing, non-judgmental language as patients may find this challenging to discuss 1.

Management Strategies

For nocturnal enuresis and urinary incontinence 1:

  • First-line: Nocturnal fluid restriction, urinating before bed, setting alarms throughout the night
  • Pharmacological: Aripiprazole augmentation has shown promise
  • Refractory cases: Desmopressin can be considered, but requires monitoring for hyponatremia

Important Caveats

The increased urine output may be transient and can occur independently of polydipsia (increased water intake) 1. While paranoid-hallucinatory schizophrenic patients drank 2-3 times more water during testing, both paranoid and non-paranoid patients showed 75% larger 24-hour urinary volumes 2. This suggests the polyuria is not simply secondary to increased intake but represents a direct drug effect on renal/bladder function.

Quality of life impact is substantial: Only one-third of affected patients seek treatment despite significant impairment, particularly from nocturnal enuresis 3. Proactive screening and intervention are essential rather than waiting for patients to report symptoms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.